Sign In
Buy AB
$36.87
-0.160 (-0.432%)
At Close: Jun 03, 2026
AB Science - Recommandation favorable du comité indépendant de revue des données de poursuivre l’étude de Phase 2 évaluant l’activité antivirale du masitinib dans le traitement du Covid-19
04:21pm, Wednesday, 14'th Sep 2022 GlobeNewswire Inc.
COMMUNIQUE DE PRESSE
AB Science - Positive recommendation of the Data and Safety Monitoring Board to continue the Phase 2 study evaluating the antiviral activity of masitinib in Covid-19
04:21pm, Wednesday, 14'th Sep 2022 GlobeNewswire Inc.
PRESS RELEASE
Invesco's (IVZ) August AUM Down on Unfavorable Market Returns
01:54pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Market depreciation, unfavorable FX movements and non-management fee-earning net outflows hurt Invesco's (IVZ) August AUM balance as it falls 2.3% from the prior month.
NVIDIA Draws Attention To Pelosi's Stock Picks
12:00am, Tuesday, 06'th Sep 2022 Investing.com
Meet the Most Trusted Financial companies in 2022, according to MarketWatch, IBD survey
04:45pm, Monday, 29'th Aug 2022 MarketWatch
Investor's Business Daily and MarketWatch join forces to find the 25 Most Trusted Financial Companies in the U.S. Check out the ranking.
IBD's 3rd Annual Customer Trust Survey: Stalwarts And Newcomers Win Praise
07:00am, Monday, 29'th Aug 2022
Customer trust is hard to earn. Amid a tough economy and stock market, a new survey found out which financial firms consumers trust with their money.
AB Science annonce avoir déposé une demande d'autorisation de mise sur le marché conditionnelle auprès de l’EMA pour le masitinib dans le traitement de la SLA
05:07pm, Wednesday, 24'th Aug 2022 GlobeNewswire Inc.
COMMUNIQUE DE PRESSE
AB Science announces that it has filed an application for conditional Marketing Authorization to EMA for masitinib in the treatment of ALS
05:07pm, Wednesday, 24'th Aug 2022 GlobeNewswire Inc.
PRESS RELEASE
AllianceBernstein (AB) Stock Up 2.3% as July AUM Rises 6.5%
10:55am, Friday, 12'th Aug 2022 Zacks Investment Research
Market appreciation and the acquisition of CarVal Investors aid AllianceBernstein's (AB) July AUM balance as it rises 6.5% from the prior month.
AllianceBernstein (AB) Stock Up 2.3% as July AUM Rises 6.5%
08:17am, Friday, 12'th Aug 2022
Market appreciation and the acquisition of CarVal Investors aid AllianceBernstein's (AB) July AUM balance as it rises 6.5% from the prior month.
Buy 10 Inflation Buster Ideal Dividend Dogs In August
12:54pm, Tuesday, 09'th Aug 2022
March-April 2022 UBS, Kiplinger, and Barrons analysts/reporters combined to list five sets of stocks sorted as: “Inflation Busters for 2022.” Those five articles revealed 48 equities, with 43 payi
AllianceBernstein: Attractive Fundamentals
10:52am, Tuesday, 02'nd Aug 2022
AllianceBernstein is a global asset manager for UHNWI, famed on the Street for its research division. Although markets are falling, we believe AB is in a position to reward investors.
AllianceBernstein Holding L.P (AB) CEO Seth Bernstein on Q2 2022 Results - Earnings Call Transcript
01:05pm, Friday, 29'th Jul 2022
AllianceBernstein Holding L.P (NYSE:AB ) Q2 2022 Results Conference Call July 29, 2022 10:00 AM ET Company Participants Mark Griffin - Head, Investor Relations Seth Bernstein - President and CEO Bill
Rising Interest Rates Will Provide A Tailwind To These Stocks
09:10am, Wednesday, 20'th Jul 2022
During rising rate environments, certain stocks may benefit as their interest income rises. Consider the following stocks for your portfolio if you're looking for stocks that may benefit in such a sit
AB to Report Second Quarter 2022 Results on July 29, 2022
02:02pm, Friday, 15'th Jul 2022
NASHVILLE, Tenn. , July 15, 2022 /PRNewswire/ -- AllianceBernstein L.P.
